Surrozen, Inc. Form 8-K Summary
Business context and reporting period
Surrozen, Inc. filed a Current Report on Form 8-K dated December 13, 2023, under Item 5.03 and Item 9.01. The filing reports a reverse stock split and related amendments to the company’s capitalization. It does not provide financial statements or results for a reporting period.
Reverse stock split and capitalization effects
- The company effected a one-for-fifteen (1:15) reverse stock split of its outstanding common stock, effective December 13, 2023.
- Every 15 shares of issued and outstanding common stock were automatically converted into one share. The common stock par value remained $0.0001 per share.
- The split also reduced shares available under the company’s equity incentive and employee stock purchase plans.
- Outstanding stock options, restricted stock units, and warrants were adjusted to reflect the split, including a reduction in the number of shares issuable and a corresponding increase in applicable exercise prices.
- No fractional shares were issued; eligible holders will receive cash in lieu of fractional shares.
- The common stock was scheduled to begin trading on a split-adjusted basis under the existing ticker symbol SRZN at market open on December 14, 2023. The post-split CUSIP is 86889P208.
- For the outstanding warrants trading under SRZNW, the post-split exercise price became $172.50 per share, compared with $11.50 before the split. The warrants will not be exercisable for fractional shares, and other warrant terms remain unchanged.
Financial metrics and liquidity
The filing text does not provide clear values for revenue, profit or loss, cash flow, margins, debt, cash, liquidity, or other operating or financial metrics.
Material changes versus the prior comparable period
The filing does not present period-over-period financial comparisons. The material corporate action is the 1:15 reverse stock split and the corresponding adjustment of equity awards, warrants, authorized plan shares, and trading details.
Guidance, outlook, risks, and unusual items
No financial guidance, operating outlook, management commentary, or new risk factors are provided. The principal unusual item is the reverse stock split, including cash payments for fractional shares and the adjustment of warrant terms.
Important facts for investors to verify
- Confirm that trading in SRZN reflected the 1:15 split-adjusted basis beginning December 14, 2023.
- Verify the post-split number of shares outstanding and shares reserved or issuable under equity plans.
- Review individual option, restricted stock unit, and warrant adjustments, including the $172.50 post-split warrant exercise price.
- Review the Certificate of Amendment filed as Exhibit 3.1 for the governing legal terms.
- Consult the company’s periodic filings for current cash, liquidity, operating results, and financing needs, which are not provided in this Form 8-K.